pillbase.ru

Gazyva

Active substance: obinutuzumab

INJECTION, SOLUTION, CONCENTRATE · OBINUTUZUMAB 1000 mg/40mL

United StatesActive

Marketing holder: Genentech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Газива®
    концентрат для приготовления раствора для инфузий, 1000 мг/40 мл, 40 мл (original in Russian, GRLS)
    ЛП-№(001150)-(РГ-RU)
    Ф. Хоффманн-Ля Рош Лтд.
  • Газива®
    концентрат для приготовления раствора для инфузий, 1000 мг/40 мл, 40 мл (original in Russian, GRLS)
    ЛП-002867
    Ф. Хоффманн-Ля Рош Лтд.
  • ОБИНУТУЗУМАБ
    субстанция-раствор, [замороженный], ~, (original in Russian, GRLS)
    ФС-001905
    Ф.Хоффманн-Ля Рош Лтд
EU 1
  • Gazyvaro
    obinutuzumab
    EMEA/H/C/002799
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3ce8-7062-831f-fae418f3351a,01a120c5-b040-785d-9419-af69b7762dd7;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-5efd-7c02-88ba-185feac18d6e;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50242-070
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 50242-070 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50242-070 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50242-070 · Verified 2026-10-09 · open in source